Medicine Progress
**INSTITUTION
Patient :
**NAME[AAA , BBB] R
MRN - **ID-NUM - MPACCOMMMRN
Age :
**AGE[in 20s] years
Sex :
Female
DOB :
**DATE[Oct 3 1977]
Author :
**NAME[XXX , WWW M]
Health Status
Summary of Hospitalization :
This **AGE[in 20s] year old , married , AA female with h/o chronic pancreatitis presents with abd pain x 3 weeks unrelieved by home regimen .
Accompanied with emesis , no diarrhea or constipation .
Past Medical History :
Recurrent pancreatitis secondary to resected adrenal tumor approximately 13 years ago
Post - partum , **DATE[Oct 2006]
Subjective / Events Overnight :
Chart and labs reviewed .
Patient seen at bedside .
Lying in bed , easily arouses but falls asleep during conversation .
c/o persistent pain and tired of chronic nature of pancreatitis .
Vital signs
**DATE[Feb 23 2007] 3:45:00 AM .
BP : systolic 137 , diastolic 91 .
Pulse : 89 beats per min .
Resp : 18 breaths / min .
Temp : 36.4 degrees Celsius .
Physical Exam
General Appearance : Young AA female in NAD .
Cardiovascular : S1 , S2 , no gallop .
RRR .
Respiratory :
CTA .
Gastrointestinal :
+ BS , soft , + tenderness in RUQ , epigastric area .
ND .
Musculoskeletal :
MAE s .
Skin :
Warm and dry .
Neurological :
Arousable , oriented x 3 .
Psychiatric :
Tearful at times , falls asleep while talking .
Current Medications : medication administration orders ( selected )
D5 1/2NS 1000 mL , IV , Start : **DATE[Feb 23 07] 6:26:00 , Infuse Rate : 125 mL / hr , Administer Over : 8 HR
docusate , 100 mg , By Mouth , BID , Drug Form : Cap , Start : **DATE[Feb 23 07] 9:00:00
Hydromorphone 1 mg / mL PCA premix 1 See Notes , IV , **DATE[Feb 23 07] 4:47:00 , Injection
lactulose , 20 gm , By Mouth , Daily , Drug Form : Syrup , PRN , Start : **DATE[Feb 23 07] 6:20:00
naloxone , 1 See Notes , IV , AS DIRECTED , Drug Form : Amp , PRN , Start : **DATE[Feb 23 07] 4:47:00
promethazine , 25 mg , IV , Q4HRS , Drug Form : Amp , PRN , Start : **DATE[Feb 23 07] 7:48:00
senna , 2 tab ( s ) , By Mouth , Daily , Drug Form : Tab , Start : **DATE[Feb 23 07] 9:00:00
sodium chloride , 10 mL , IV , AS DIRECTED , Drug Form : Vial , PRN , Start : **DATE[Feb 23 07] 4:47:00
zolpidem , 10 mg , By Mouth , At Bedtime , Drug Form : Tab , PRN , Start : **DATE[Feb 23 07] 6:21:00
General Results
Today 's results :
ALLRESLTSECT
**DATE[Feb 23 2007] 12:14 AM
Na 142 mEq / L
K 3.9 mEq / L
Cl 105 mEq / L
CO2 23 mEq / L
Anion Gap 14.0 High
BUN 7 mg / dL
Cr 0.8 mg / dL
Amylase 116 IU / L High
Lipase 235 IU / L High
WBC 6.9 X10E+09 / L
RBC 4.26 X10E+12 / L
Hgb 12.8 gm / dL
Hct 37.0 %
MCV 86.8 fL
MCH 30.1 pg
MCHC 34.7 gm / dL
RDW 14.9 %
MPV 9.0 fL
Platelets 279 X10E+09 / L
Neutrophils 61 %
Lymphs 30 %
Monocytes 8 %
Eosinophils 1 %
Basophils 0 %
ABS Neutrophils 4.20 X10E+09 / L
ABS Lymphs 2.10 X10E+09 / L
ABS Monocytes 0.60 X10E+09 / L
ABS Eosinophils 0.10 X10E+09 / L
ABS Basophils 0.00 X10E+09 / L
Type of Differential
Automated Differential
Impression and Plan
Plan
1. GI - h/o chronic pancreatitis secondary to adrenal gland tumor 13 years ago .
Admitted with recurrent pancreatitis .
Dilaudid 4 mg PCA decreased to 2 mg by attending .
Patient c/o that 2 mg NOT helping and she was so groggy this am due to 0500 Ambien .
Discussed with Dr. **NAME[ZZZ] , will increase to 3 mg .
Will advance diet as tolerated beginning with clears and graham crackers .
2. Psych - contacted by nursing staff for social service consult re : patient 's chronic pancreatitis and her response to living with this .
3. Disposition - d/c to home when medically stable .
Case discussed with Dr. **NAME[ZZZ] .
ADDENDUM :
Discussed at length with patient her frustration with living with chronic condition .
Patient does NOT want to speak with Social Service , clergy or other " therapists " as she doesn 't want labelled -" anxiety " .
I re - addressed Dilaudid dosing with Dr. **NAME[ZZZ] as patient appeared not satisfied with my explanation of concern that she is unable to stay awake and doesn 't remember Dr. **NAME[ZZZ] rounding this am .
Patient insists the ambien is the reason NOT dilaudid .
Patient to stay at 3 mg Dilaudid and maximize dosing .
Will re - evaluate once patient maximizes dosing .
Professional Services
Credentials and Title of Author **NAME[VVV] Signing this **NAME[UUU] : CRNP
Perform by **NAME[XXX , WWW] R
( on **DATE[Feb 23 2007] 18:19 )
Sign by **NAME[XXX , WWW] R
( on **DATE[Feb 23 2007] 18:19 )
VERIFY by **NAME[XXX , WWW] R
( on **DATE[Feb 23 2007] 18:19 )
